Practical Phlebology: Deep Vein Thrombosis by Anthony J. Comerota, Lowell S. Kabnick, Neil S. Sadick |, Hardcover | Barnes & Noble
Practical Phlebology: Deep Vein Thrombosis

Practical Phlebology: Deep Vein Thrombosis

by Anthony J. Comerota, Lowell S. Kabnick, Neil S. Sadick
     
 

Deep Vein Thrombosis, the latest volume in the Practical Phlebology Series, provides the phlebologist with the ideal illustrative guide to the aetiology, diagnosis and management of DVT.

Overview

Deep Vein Thrombosis, the latest volume in the Practical Phlebology Series, provides the phlebologist with the ideal illustrative guide to the aetiology, diagnosis and management of DVT.

Editorial Reviews

Doody's Review Service
Reviewer: Courtney M Daly, MD (Northwestern University Feinberg School of Medicine)
Description: Part of the Practical Phlebology series created to help clinicians caring for patients with venous disease, this book focuses on deep vein thrombosis (DVT).
Purpose: The purpose is to explain the disease process, including prevalence and etiology, as well as to review current recommendations for treatment and optimal patient care.
Audience: The audience includes any clinicians who wish to increase their knowledge of DVT, since it is so prevalent in both medical and surgical patients. The book would be a valuable tool for current practitioners as well as trainees in medical and surgical fields. One of the leaders in the field, the author has contributed to the development of the newest treatment for vascular disease, participated in pivotal clinical trials, and authored numerous publications.
Features: This book is thorough and precise in its description of deep venous thrombosis. It starts with the natural history and etiology of DVT before moving on to discuss current recommendations for DVT prophylaxis, diagnosis of DVT, and management of acute DVT. It does an excellent job of concisely summarizing and providing an evidence-based explanation of current recommendations. This includes a discussion of well-known anticoagulants as well as a comprehensive summary of new oral anticoagulants. One chapter covers interventional treatment of DVT, specifically thrombus removal techniques, and inferior cava filters. The book ends with chapters on heparin-induced thrombocytopenia as well as the technique of common femoral endovenectomy and endoluminal recanalization for chronic post thrombosis iliofemoral venous obstruction. Highlights include a very clear yet thorough explanation of why all DVTs are not the same, and the chapter on new oral anticoagulants, which is comprehensive yet succinct.
Assessment: This is an invaluable book for any clinicians wishing to increase their knowledge about DVT and how to care for patients with this disease process. It is well written with complete yet understandable explanations of the disease process and how to treat patients with each type of DVT. It provides current recommendations as well as evidence-based explanations. Given the prevalence of DVT across many fields of medicine and surgery, clinicians of any specialty would benefit from this book.

Product Details

ISBN-13:
9781444146097
Publisher:
Taylor & Francis
Publication date:
01/16/2014
Series:
Practical Phlebology Series
Pages:
149
Product dimensions:
7.50(w) x 9.80(h) x 0.60(d)

Meet the Author

Anthony J. Comerot, MD, FACS, FACC, is the director of the Jobst Vascular Institute at Toledo Hospital in Ohio and adjunct professor of surgery at the University of Michigan. He received his medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania, and completed his general surgery residency at Temple University Hospital and his vascular surgery fellowship at Good Samaritan Hospital, Cincinnati, Ohio.

Dr. Comerota has been a major contributor to the development of some of the newest forms of treatment for vascular disease and has been the principal investigator of seven major national trials and a co-investigator of numerous others. His research interests span a broad range of arterial and venous disorders, including the management of acute DVT, therapeutic angiogenesis, noninvasive diagnosis of vascular disease, development of new devices, new drug development, and the effects of platelet-inhibiting drugs. He has received over $5 million in research funding, including support from the National Institutes of Health (NIH), the American Heart Association, and the American Diabetes Association.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >